124 related articles for article (PubMed ID: 2461585)
1. Synthesis of soluble C3 and C9 neoepitopes by human alveolar macrophages in vitro.
Pettersen HB; Johnson E; Mollnes TE; Garred P
Scand J Immunol; 1988 Oct; 28(4):431-4. PubMed ID: 2461585
[TBL] [Abstract][Full Text] [Related]
2. Human alveolar macrophages synthesize the functional alternative pathway of complement and active C5 and C9 in vitro.
Hetland G; Johnson E; Aasebø U
Scand J Immunol; 1986 Nov; 24(5):603-8. PubMed ID: 3787189
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of complement by alveolar macrophages from patients with sarcoidosis.
Pettersen HB; Johnson E; Mollnes TE; Garred P; Hetland G; Osen SS
Scand J Immunol; 1990 Jan; 31(1):15-23. PubMed ID: 1689072
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a monoclonal antibody MoAb bH6 reacting with a neoepitope of human C3 expressed on C3b, iC3b, and C3c.
Garred P; Mollnes TE; Lea T; Fischer E
Scand J Immunol; 1988 Mar; 27(3):319-27. PubMed ID: 2451273
[TBL] [Abstract][Full Text] [Related]
5. Human alveolar macrophages synthesize active complement components C6, C7, and C8 in vitro.
Pettersen HB; Johnson E; Hetland G
Scand J Immunol; 1987 Jun; 25(6):567-70. PubMed ID: 3602933
[TBL] [Abstract][Full Text] [Related]
6. Human umbilical vein endothelial cells synthesize functional C3, C5, C6, C8 and C9 in vitro.
Johnson E; Hetland G
Scand J Immunol; 1991 Jun; 33(6):667-71. PubMed ID: 2047760
[TBL] [Abstract][Full Text] [Related]
7. Human peritoneal macrophages. Production in vitro of the active terminal complement components C5 to C9 and a functional alternative pathway of complement. Brief report.
Hetland G; Bungum L
APMIS; 1988 Jan; 96(1):89-92. PubMed ID: 3345254
[TBL] [Abstract][Full Text] [Related]
8. Quantification in enzyme-linked immunosorbent assay of a C3 neoepitope expressed on activated human complement factor C3.
Garred P; Mollnes TE; Lea T
Scand J Immunol; 1988 Mar; 27(3):329-35. PubMed ID: 2451274
[TBL] [Abstract][Full Text] [Related]
9. A sensitive method to detect synthesis of the functional classical, alternative and terminal pathway of complement by cells cultured in vitro.
Johnson E; Hetland G
Scand J Clin Lab Invest; 1988 May; 48(3):223-31. PubMed ID: 3287591
[TBL] [Abstract][Full Text] [Related]
10. Functional assessment of mouse complement pathway activities and quantification of C3b/C3c/iC3b in an experimental model of mouse renal ischaemia/reperfusion injury.
Kotimaa JP; van Werkhoven MB; O'Flynn J; Klar-Mohamad N; van Groningen J; Schilders G; Rutjes H; Daha MR; Seelen MA; van Kooten C
J Immunol Methods; 2015 Apr; 419():25-34. PubMed ID: 25733354
[TBL] [Abstract][Full Text] [Related]
11. Lytic rabbit IgG for tissue culture trypomastigotes of Trypanosoma cruzi alters the extent and form of complement deposition.
Rimoldi MT; Tartanian A; Joiner KA
Exp Parasitol; 1989 Feb; 68(2):160-7. PubMed ID: 2647504
[TBL] [Abstract][Full Text] [Related]
12. Blood dendritic cells carry terminal complement complexes on their cell surface as detected by newly developed neoepitope-specific monoclonal antibodies.
Würzner R; Xu H; Franzke A; Schulze M; Peters JH; Götze O
Immunology; 1991 Sep; 74(1):132-8. PubMed ID: 1718850
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of C3, C5, C6, C7, C8, and C9 by human fibroblasts.
Garred P; Hetland G; Mollnes TE; Stoervold G
Scand J Immunol; 1990 Nov; 32(5):555-60. PubMed ID: 2270435
[TBL] [Abstract][Full Text] [Related]
14. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.
Falk RJ; Dalmasso AP; Kim Y; Tsai CH; Scheinman JI; Gewurz H; Michael AF
J Clin Invest; 1983 Aug; 72(2):560-73. PubMed ID: 6348093
[TBL] [Abstract][Full Text] [Related]
15. Phagocytosis of agarose beads by receptors for C3b (CR1) and iC3b (CR3) on alveolar macrophages from patients with sarcoidosis.
Pettersen HB; Johnson E; Osen SS
Scand J Immunol; 1990 Dec; 32(6):669-77. PubMed ID: 2148644
[TBL] [Abstract][Full Text] [Related]
16. Phagocytosis of agarose beads by receptors for C3b (CR1) and iC3b (CR3) on human alveolar macrophages cultured on fibronectin in vitro. A scanning electron microscopic study.
Johnson E; Larsen T; Hetland G
Scand J Immunol; 1986 Dec; 24(6):653-60. PubMed ID: 2948272
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of complement components C5, C6, C7, C8 and C9 in vitro by human monocytes and assembly of the terminal complement complex.
Hetland G; Johnson E; Falk RJ; Eskeland T
Scand J Immunol; 1986 Oct; 24(4):421-8. PubMed ID: 3764345
[TBL] [Abstract][Full Text] [Related]
18. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
[TBL] [Abstract][Full Text] [Related]
19. Clusterin and the terminal complement pathway synthesized by human umbilical vein endothelial cells are closely linked when detected on co-cultured agarose beads.
Berge V; Johnson E; Høgåsen K
APMIS; 1997 Jan; 105(1):17-24. PubMed ID: 9063496
[TBL] [Abstract][Full Text] [Related]
20. Human alveolar macrophages and monocytes generate the functional classical pathway of complement in vitro.
Hetland G; Johnson E; Røyset P; Eskeland T
Acta Pathol Microbiol Immunol Scand C; 1987 Jun; 95(3):117-22. PubMed ID: 3630715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
